Systematic Pelvic and Aortic Lymphadenectomy in Advanced Ovarian Cancer Patients at the Time of Interval Debulking Surgery: A Double-Institution Case

Systematic Pelvic and Aortic Lymphadenectomy in Advanced Ovarian Cancer Patients at the Time of Interval Debulking Surgery: A Double-Institution Case–Control Study

Published:2012-05-30 Issue:11 Volume:19 Page:3522-3527
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Fagotti Anna,De Iaco Pierandrea,Fanfani Francesco,Vizzielli Giuseppe,Perelli Federica,Pozzati Federica,Perrone Anna Myriam,Turco Luigi Carlo,Scambia Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-012-2400-9.pdf

Reference24 articles.

1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. Version 2.2012. NCCN.org. http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf . Accessed 1 Mar 2012.

2. Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560–6.

3. Eisenkop SM, Freiedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol. 1998;69:103–8.

4. Schwartz PE. Neoadjuvant chemotherapy for the management of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2002;16:585–96.

5. Ozols RF. Management of advanced ovarian cancer consensus summary. Advanced Ovarian Cancer Consensus Faculty. Semin Oncol. 2000;27:47–9.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database;Journal of Cancer Research and Clinical Oncology;2023-09-14

2. Assessing the Feasibility of Laparoscopic Interval Cytoreduction in Advanced Epithelial Ovarian Cancer;Indian Journal of Gynecologic Oncology;2023-05-12

3. Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes;Clinical and Experimental Obstetrics & Gynecology;2023-04-13

4. Surgical management of patients with advanced ovarian cancer: Results of a French National Survey;Journal of Gynecology Obstetrics and Human Reproduction;2022-11

5. Risks and benefits of systematic lymphadenectomy during interval debulking surgery for advanced high grade serous ovarian cancer;European Journal of Surgical Oncology;2022-01